T38.5X2A Poisoning by other estrogens and progestogens, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by other estrogens and progestogens, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting from poisoning by other estrogens and progestogens during an initial encounter. It covers harmful effects from deliberate exposure to these hormonal agents, which may occur due to intentional overdose or misuse. The code applies to the acute phase of care when the patient first presents for treatment.

Causes

The causes include intentional overdose or misuse of estrogens or progestogens, often involving self-administered doses exceeding therapeutic limits. This may stem from deliberate self-harm, misuse of prescribed or non-prescribed hormonal agents, or intentional ingestion of products containing these substances.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Access to estrogen or progestogen-containing medications (e.g., contraceptives, hormone therapies)
• Mental health conditions affecting judgment or impulse control
• Polypharmacy involving hormonal agents
• Individual sensitivity to hormonal substances

Symptoms

Symptoms vary based on the specific agent and dose but may include nausea, vomiting, abdominal pain, dizziness, or changes in menstrual patterns. Severe cases could involve thromboembolic events, hepatic dysfunction, endocrine disturbances, or central nervous system effects.

Diagnosis

Diagnosis requires a thorough patient history, including medication use, exposure details, and intent. Clinical evaluation focuses on identifying signs of poisoning, such as altered mental status, organ toxicity, or metabolic disturbances. Laboratory tests may assess drug levels, organ function, or toxicology screens.

Treatment Options

Treatment involves stabilizing the patient, managing acute symptoms, and addressing the underlying intent. Interventions may include decontamination, supportive care, antidote administration (if available), and psychiatric evaluation. Long-term management may involve mental health support and safety planning.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of care, and underlying health. Follow-up includes monitoring for delayed effects, assessing mental health, and ensuring adherence to treatment plans. Regular check-ins with healthcare providers and mental health professionals are typically recommended.

Complications

Complications may include organ damage (e.g., hepatic or renal), thromboembolic events, endocrine imbalances, or psychological sequelae. Severe cases can lead to life-threatening conditions requiring intensive care.

Lifestyle & Prevention

Prevention focuses on secure storage of medications, education on proper use, and addressing mental health needs. Support systems and crisis resources may help reduce the risk of intentional self-harm.

When to Seek Professional Help

Seek immediate medical attention if poisoning is suspected, especially with intentional self-harm. Signs include altered consciousness, severe symptoms, or uncertainty about exposure. Prompt care is critical to mitigate harm.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Ensure the code aligns with clinical documentation of the poisoning event and initial treatment phase. Verify that the agent is classified as "other estrogens and progestogens" and that the scenario matches the code’s specificity.